SCM
IDXX icon

Sone Capital Management’s Idexx Laboratories IDXX Stock Holding History

Sone Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.97M Buy
+18,931
New +$10.6M 0.76% 54
2026
Q1 		– Sell
-5,991
Closed -$4.05M – 114
2025
Q4 		$4.05M Sell
5,991
-1,262
-17% -$859K 0.33% 80
2025
Q3 		$4.63M Buy
+7,253
New +$4.4M 0.39% 79
2025
Q2 		– Sell
-25,986
Closed -$10.9M – 113
2025
Q1 		$10.9M Buy
25,986
+11,710
+82% +$5.08M 1.12% 36
2024
Q4 		$5.9M Buy
+14,276
New +$6.26M 0.75% 58

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sone Capital Management's IDXX Position: Q2 2026 in Review

Sone Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 18,931 shares worth $9.97M. The stake represents 0.76% of the portfolio and ranks #54 among its holdings. This is a return to the name: Sone Capital Management previously reported a position in IDXX as recently as Q4 2025.

Sone Capital Management first reported a position in IDXX in Q4 2024 and has held it in 5 quarters since. The position peaked at $10.9M in Q1 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sone Capital Management held 18,931 shares of Idexx Laboratories worth $9.97M as of Q2 2026.
  • Idexx Laboratories was a new Sone Capital Management position in Q2 2026.
  • Idexx Laboratories made up 0.76% of Sone Capital Management's portfolio in Q2 2026, its #54 holding.
  • Sone Capital Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 5 quarters since.
  • Sone Capital Management's Idexx Laboratories position peaked at $10.9M in Q1 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.